Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Takotsubo Cardiomyopathy | 1 | 2021 | 20 | 0.670 |
Why?
|
| Occupational Stress | 1 | 2020 | 13 | 0.640 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2020 | 97 | 0.600 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 393 | 0.580 |
Why?
|
| Kidney Diseases | 1 | 2022 | 472 | 0.550 |
Why?
|
| Mental Health | 1 | 2020 | 371 | 0.500 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 519 | 0.470 |
Why?
|
| Health Personnel | 1 | 2020 | 549 | 0.450 |
Why?
|
| Anxiety | 1 | 2020 | 1007 | 0.400 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 646 | 0.390 |
Why?
|
| Depression | 1 | 2020 | 1317 | 0.340 |
Why?
|
| Vagina | 1 | 2026 | 201 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2026 | 284 | 0.190 |
Why?
|
| Bacteria | 1 | 2026 | 518 | 0.180 |
Why?
|
| Marijuana Abuse | 1 | 2021 | 50 | 0.170 |
Why?
|
| Cannabis | 1 | 2021 | 49 | 0.170 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2020 | 6 | 0.170 |
Why?
|
| Microbiota | 1 | 2026 | 435 | 0.160 |
Why?
|
| Amiodarone | 1 | 2020 | 48 | 0.160 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2020 | 8 | 0.160 |
Why?
|
| Septal Occluder Device | 1 | 2021 | 47 | 0.160 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 45 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2021 | 135 | 0.150 |
Why?
|
| Drug-Eluting Stents | 1 | 2020 | 67 | 0.150 |
Why?
|
| Chest Pain | 1 | 2020 | 123 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2020 | 152 | 0.140 |
Why?
|
| Bipolar Disorder | 1 | 2021 | 346 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2021 | 542 | 0.140 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 213 | 0.140 |
Why?
|
| Heart Valve Prosthesis | 1 | 2021 | 301 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1880 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2020 | 256 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2020 | 453 | 0.130 |
Why?
|
| Social Support | 1 | 2020 | 363 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 550 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 228 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 425 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2020 | 283 | 0.120 |
Why?
|
| Echocardiography | 1 | 2021 | 1127 | 0.110 |
Why?
|
| Humans | 10 | 2026 | 130496 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1159 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 1929 | 0.080 |
Why?
|
| Middle Aged | 4 | 2026 | 28448 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2564 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12850 | 0.070 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2026 | 6 | 0.060 |
Why?
|
| Rheumatoid Factor | 1 | 2026 | 8 | 0.060 |
Why?
|
| Inpatients | 2 | 2021 | 559 | 0.060 |
Why?
|
| Female | 6 | 2026 | 70401 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 20928 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2026 | 375 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2026 | 445 | 0.050 |
Why?
|
| Male | 4 | 2021 | 64498 | 0.050 |
Why?
|
| Electric Countershock | 1 | 2020 | 75 | 0.040 |
Why?
|
| Cytokines | 1 | 2026 | 1342 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2021 | 244 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2021 | 245 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 335 | 0.030 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 118 | 0.030 |
Why?
|
| Adult | 3 | 2026 | 31183 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 3807 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 623 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1343 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1228 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2019 | 1064 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 973 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1395 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 749 | 0.020 |
Why?
|
| Young Adult | 1 | 2026 | 10010 | 0.020 |
Why?
|
| Adolescent | 1 | 2026 | 20739 | 0.020 |
Why?
|
| United States | 1 | 2019 | 11877 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17554 | 0.010 |
Why?
|